文章基本信息

标题：IN VIVO CONVERSION OF PEPTIDE DRUGS INTO HIGH MOLECULAR WEIGHT FORMS
本地全文：下载
作者：RYOHEI HORI ; YOSHIHIRO SAITO ; MASATO YASUHARA 等
期刊名称：Biological and Pharmaceutical Bulletin
印刷版ISSN：0918-6158
电子版ISSN：1347-5215
出版年度：1984
卷号：7
期号：12
页码：910-916
DOI：10.1248/bpb1978.7.910
出版社：The Pharmaceutical Society of Japan
摘要：Following injection of ¹²⁵I-porcine insulin, ¹²⁵I-aprotinin, ¹²⁵I-salmon calcitonin, or ¹²⁵I-(Asu^{1, 7}-eel calcitonin into rats, high molecular weight (HMW) forms of these peptides were detected in serum or plasma when analyzed by gel chromatography. The conversion into HMW forms occurred after 1) intravenous bolus injection of insulin, aprotinin, or calcitonins, 2) intravenous infusion of insulin or aprotinin, and 3) subcutaneous injection of insulin, indicating that HMW forms were produced in the general circulation not in the subcutaneous tissue. Rechromatography of HMW forms produced in vivo from insulin or aprotinin showed the release of lower moleclar weight component which was eluted at the same position of parent peptide, the immunoreactivity of the released component derived from insulin was almost the same as for insulin. These results suggest that the conversion of peptide drugs into HMW forms is generally occurred in vivo and they play a role as a depot in circulation.
关键词：immunoassay